P

Inventor

BRADNER JAMES E

US37 patents
⚠️ This page may combine multiple inventors who share the name “BRADNER JAMES E”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

DANA FARBER CANCER INST INC

18 patents
US9714946B2Jul 25, 2017

Bromodomain binding reagents and uses thereof

DANA FARBER CANCER INST INC41 citations94
US10308653B2Jun 4, 2019

Diazepane derivatives and uses thereof

DANA FARBER CANCER INST INC8 citations84
US10150756B2Dec 11, 2018

Diaminopyrimidine benzenesulfone derivatives and uses thereof

DANA FARBER CANCER INST INC9 citations84
US9975896B2May 22, 2018

Inhibitors of transcription factors and uses thereof

DANA FARBER CANCER INST INC17 citations83
US9695172B2Jul 4, 2017

Diazepane derivatives and uses thereof

DANA FARBER CANCER INST INC13 citations83
US11306105B2Apr 19, 2022

Cyano thienotriazolodiazepines and uses thereof

DANA FARBER CANCER INST INC3 citations73
US10881668B2Jan 5, 2021

Acetamide thienotriazolodiazepines and uses thereof

DANA FARBER CANCER INST INC4 citations73
US9951074B2Apr 24, 2018

Dihydropteridinone derivatives and uses thereof

DANA FARBER CANCER INST INC6 citations73
US10793571B2Oct 6, 2020

Uses of diazepane derivatives

DANA FARBER CANCER INST INC2 citations72
US11406645B2Aug 9, 2022

Acetamide thienotriazolodiazepines and uses thereof

DANA FARBER CANCER INST INC0 citations62
US11236082B2Feb 1, 2022

EZH2 inhibitors and uses thereof

DANA FARBER CANCER INST INC0 citations62
US10730860B2Aug 4, 2020

Diaminopyrimidine benzenesulfone derivatives and uses thereof

DANA FARBER CANCER INST INC1 citations62
US10913752B2Feb 9, 2021

Bivalent bromodomain inhibitors and uses thereof

DANA FARBER CANCER INST INC1 citations61
US11446309B2Sep 20, 2022

Combination therapy for cancer using bromodomain and extra-terminal (BET) protein inhibitors

DANA FARBER CANCER INST INC0 citations59
US11666580B2Jun 6, 2023

Mechanism of resistance to bet bromodomain inhibitors

DANA FARBER CANCER INST INC0 citations53
US9458165B2Oct 4, 2016

DOT1L inhibitors

DANA FARBER CANCER INST INC0 citations49
US10633371B2Apr 28, 2020

EZH2 inhibitors and uses thereof

DANA FARBER CANCER INST INC0 citations38
US9535067B2Jan 3, 2017

DOT1L probes

DANA FARBER CANCER INST INC0 citations38

HARVARD COLLEGE

5 patents

VAN DUZER JOHN H

3 patents

UNIV COLORADO STATE RES FOUND

3 patents

WILLIAMS ROBERT M

2 patents

ANDERSON KENNETH C

1 patent

BROAD INST INC

1 patent

ACETYLON PHARMACEUTICALS INC

1 patent

NOVARTIS AG

1 patent

WHITEHEAD INST BIOMEDICAL RES

1 patent

UNIV BOSTON

1 patent